Fabienne Steens
Directeur en chef des Investissements chez Biomedical Diagnostics NV
Profil
Fabienne Steens has worked as the Managing Director & Director at Biomedical Diagnostics NV since 2003.
Postes actifs de Fabienne Steens
| Sociétés | Poste | Début |
|---|---|---|
Biomedical Diagnostics NV
 Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Directeur en chef des Investissements | 28/01/2003 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Biomedical Diagnostics NV
Biomedical Diagnostics NV Medical DistributorsDistribution Services Part of Eurobio-Scientific SA, Biomedical Diagnostics NV was founded in 2003 and is a Belgian company that provides high-quality reagents and reliable instruments for in vitro diagnostics in the Benelux. The company is based in Antwerp, Belgium. Biomedical Diagnostics offers collection and preservation products that protect sample integrity during transportation and storage, ensuring preanalytical variables are controlled and the samples are protected. The company's products include blood collection tubes, cell-free DNA BCT, RNA complete BCT, and Cyto-Chex BCT. Additionally, Biomedical Diagnostics offers stabilization reagents such as Streck cell preservative and Streck cell-free DNA urine preserve. On June 13, 2022, Biomedical Diagnostics was acquired by Eurobio-Scientific SA. | Distribution Services |